11|20|24

The Evolution of Search: How OpenAI’s SearchGPT Enhances ChatGPT’s Capabilities

After nearly a year of stagnant growth, ChatGPT is gaining momentum once again. In this POV, we explore the future of search behavior and emphasize the importance for life science organizations to understand OpenAI’s latest innovation incorporating SearchGPT directly into ChatGPT.

11|18|24

What Matters Most: The Three Trends That Will Change Pharma Marketing in 2025

This year’s EVERSANA INTOUCH annual trends forecast – our ninth! – is both smaller and bigger than those that have come before it. Technology (No. 1: applied AI) is enabling entirely new ways to do business (No. 2: the direct-to-patient model) in a paradigm that’s interconnected (No. 3: globalization and health equity) at every level. […]

11|08|24

Art Meets AI: Inside EVERSANA INTOUCH’s Artful Ingenuity Campaign

In an exclusive feature with MM+M, Chief Creative Officer Susan Perlbachs shared insights into Artful Ingenuity, EVERSANA INTOUCH’s latest campaign highlighting the agency’s commitment to data-driven, creative, and AI-powered AOR services.  At its core, Artful Ingenuity aims to reinforce EVERSANA INTOUCH’s position as the global agency network that delivers breakthrough thinking and reliable execution. By […]

10|24|24

Can a Celebrity Influencer Work for Your Brand?

In a recent article for PM360, Susan Perlbachs, Chief Creative Officer at EVERSANA INTOUCH, delves into the growing trend of celebrity influencers in pharmaceutical advertising, exploring both the opportunities and challenges they present. She highlights how celebrities can provide brands with instant recognition and broad reach, sharing examples like Travis Kelce’s involvement in Pfizer’s “Got […]

10|22|24

Scaling Success: Transforming Pharma Marketing With Data-Driven Insights

In the dynamic world of pharmaceutical marketing, staying ahead requires innovation and advanced data analytics to provide valuable insights and achieve brand success. Joey Morrissey, Senior Director, Analytics, recently presented various data and analytics business use cases during a webinar highlighting how EVERSANA INTOUCH drives business impact using Tableau Pulse.

10|18|24

The Real Threat to Creatives Isn’t GenAI; It’s a Content Supply Chain That Can’t Keep Pace With Their Innovation

As we stand at the intersection of creativity and technology, a common question arises: Will generative AI (GenAI) make creatives obsolete? Susan Perlbachs, Chief Creative Officer, details why the answer that echoed through Adobe MAX 2024 was a firm no. Read the blog to learn more.

10|15|24

Lead Time Is All You Need: Patient Identification for Cell and Gene Therapies

Discover how EVERSANA’s cutting-edge approach is revolutionizing patient identification for cell and gene therapies. In our white paper, “Lead Time Is All You Need: Patient Identification for Cell and Gene Therapies Using Machine Learning and Advanced Data Analytics,” we explore the transformative power of machine learning and advanced data analytics in the world of healthcare.

10|07|24

How AI Makes the Voice of the Consumer Louder

Artificial intelligence is revolutionizing the way companies make marketing decisions. John Kenny, EVP and Head of Strategic Planning, delves into the innovative use of AI-powered personas to keep the customer’s perspective central in marketing strategies.

10|04|24

EVERSANA INTOUCH Shines at the 2024 PM360 Trailblazer Awards with Five Wins 

The 16th annual PM360 Trailblazer Awards was a night to remember for EVERSANA INTOUCH! Our team was honored at Gotham Hall in New York City, taking home five awards across several categories: 

09|30|24

Angela Tenuta on How Brands Can Transform their Content Velocity

Taking a deeper dive into our recent POV, Content Velocity: Mastering the Three Pillars of Success, Angela Tenuta, President, Agency, covers how pharmaceutical companies can master content velocity to deliver brand content with unparalleled speed, precision and reach in pharmaphorum’s most recent Deep Dive Magazine.